Advertisement
Research Article

Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino Oligomers

  • Kelly L Warfield equal contributor,

    equal contributor Contributed equally to this work with: Kelly L Warfield, Dana L Swenson

    Affiliation: US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America

    X
  • Dana L Swenson equal contributor,

    equal contributor Contributed equally to this work with: Kelly L Warfield, Dana L Swenson

    Affiliation: US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America

    X
  • Gene G Olinger,

    Affiliation: US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America

    X
  • Donald K Nichols,

    Affiliation: US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America

    X
  • William D Pratt,

    Affiliation: US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America

    X
  • Robert Blouch,

    Affiliation: AVI BioPharma, Corvallis, Oregon, United States of America

    X
  • David A Stein,

    Affiliation: AVI BioPharma, Corvallis, Oregon, United States of America

    X
  • M. Javad Aman,

    Affiliation: US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America

    X
  • Patrick L Iversen,

    Affiliation: AVI BioPharma, Corvallis, Oregon, United States of America

    X
  • Sina Bavari mail

    To whom correspondence should be addressed. E-mail: sina.bavari@amedd.army.mil

    Affiliation: US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America

    X
  • Published: January 13, 2006
  • DOI: 10.1371/journal.ppat.0020001

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.